NFE2L2 and malignant colon neoplasm: Because Nrf2 is involved in colitis and associated with colon cancer, we believe it would be significant to examine the ability of AG, HAG, and PA to target Nrf2 as a mechanism for the protection of colitis and colon cancer [38,39,40].